|Printable version||E-mail this to a friend|
Dijsselbloem: concerns about flexible application Stability & Growth Pact rules
Dutch finance minister and ECOFIN Chair Jeroen Dijsselbloem worries that the way in which the EU Commission applies Stability and Growth Pact rules may not be entirely objective, he told Economic and Monetary Affairs Committee MEPs on Tuesday. At a meeting reviewing the Dutch Presidency of the Council of Economy and Finance Ministers, he said he hoped that on Friday 17 June they would agree a road map for completing the Banking Union with a European Deposit Guarantee Scheme (EDIS).
Stability and Growth Pact: No special treatment for France "because it is France"
Several MEPs asked Mr Dijsselbloem about his criticism of Commission President Jean-Claude Juncker, who had hinted the Commission’s treatment of France under Stability and Growth Pact differs "because it is France". "If we have an agreement between us, it is important that all of us comply. The role of the Commission is crucial when it comes to interpretation of flexibility rules and if member states feel that the Commission's decisions are not objective - that big countries are treated differently than small countries - that worries me. Ministers are concerned. The Commission is the guardian of the treaties and should act on clear, transparent and objective grounds", Mr Dijsselbloem explained.
European Deposit Insurance Scheme
Mr Dijsselbloem said he hoped that ministers at the 17 June ECOFIN meeting would agree a road map for completing the Banking Union by 2024. Several MEPs urged that it should be done sooner. Others expressed concerns about the balance between risk reduction and risk sharing, given that the banking sector is not equally robust in all member states. Mr Dijsselbloem said that the single resolution fund for failing banks would be filled gradually until 2024 and that the same went for a deposit guarantee insurance scheme. "But meanwhile, many banks have to cope with non-performing loans and high concentrations of sovereign bonds on their balance sheets and this needs time to be dealt with", he said.
UK's EU-referendum: "I want the UK to become an active member again"
Asked about German Finance Minister Wolfgang Schäuble’s remarks on the UK’s EU referendum – that "In is in, out is out" – Mr Dijsselbloem said that, based on the Dutch experiences with referendums, "it is of no use to threaten the voters.” But there is a good argument for European cooperation, he added. "Take the example of immigration. Problems don't go away if the UK decides to leave the EU. (..) I want the United Kingdom to become an active EU-member again. "
Anti-corporate tax avoidance: no watered-down compromise
Asked why the Dutch Presidency had not managed to strike a deal among ministers on the draft EU anti-tax avoidance directive, which should translate the OECD action plan against base erosion and profit shifting into EU law, Mr Dijsselbloem said he wanted it to be “a strong and credible directive, not a watered down compromise."
Statement by Dijsselbloem (Click on name to view the statements in full)
Political group speakers (Click on name to view the statements in full)
Latest News from
EU scales up its assistance against cholera outbreak in Yemen26/06/2017 16:05:00
The EC is scaling up its response to an unprecedented cholera outbreak in Yemen with an additional €5m, bringing total EU support for efforts to tackle the disease to €8.8m.
Investments in EU Transport: Commission proposes €2.7bn for 152 projects26/06/2017 15:15:15
Recently the European Commission proposed to invest €2.7 billion in 152 key transport projects that support competitive, clean and connected mobility in Europe.
Europe’s shrinking middle class26/06/2017 14:25:00
In the follow blog piece, originally posted on Social Europe, Carlos Vacas-Soriano and Enrique Fernández-Macías look at evolution of household disposable real income levels over the period 2004-2013, and the broader phenomenon on Europe's shrinking middle class.
First ever guidance for stem cell therapies in animals published26/06/2017 13:10:00
Document gives advice on sterile manufacturing processes for veterinary stem cell medicines.
EMA recommends that Symbioflor 2 can continue to be used for irritable bowel syndrome26/06/2017 12:44:00
A review by the EMA has concluded that Symbioflor 2 and associated names can continue to be used for treatment of irritable bowel syndrome (IBS) in adults. However, the medicine should no longer be used more widely to treat so-called functional gastrointestinal disorders.